Maryland 2024 Regular Session

Maryland House Bill HB691

Introduced
1/25/24  

Caption

Legally Protected Health Care - Gender-Affirming Treatment

Summary

House Bill 691, titled 'Legally Protected Health Care - Gender-Affirming Treatment', aims to amend state laws regarding the definition of legally protected health care to explicitly include gender-affirming treatments. These treatments encompass a range of medical services, including hormone therapy, surgeries, and other procedures related to gender identity. This bill is a response to growing concerns about the protection of health care practitioners providing or supporting gender-affirming care, and its implications for both practitioners and patients are significant. The legislation seeks to prevent state boards from disciplining health care providers for delivering such care, thereby reinforcing the protections offered under Maryland law. Furthermore, HB691 stipulates that no action can be taken against health care practitioners based on disciplinary actions from other states, provided that their actions are in accordance with Maryland's legal and medical standards. This provision is designed to protect practitioners who may face legal repercussions in states with more restrictive laws regarding gender-affirming care, ensuring that they can provide necessary services without the fear of losing their licenses in Maryland. The bill was introduced on January 25, 2024, and has garnered various opinions from lawmakers and advocacy groups. Supporters argue that HB691 is a crucial step toward affirming the rights of individuals seeking gender-affirming treatments and safeguarding medical professionals who assist them. On the other hand, some critics view the bill as controversial, suggesting that it could lead to conflicts with states that prohibit such treatments. The discussions around this bill highlight the broader national debate regarding gender identity and health care access, reflecting the increasing polarization on these issues. If passed, House Bill 691 will take effect on October 1, 2024, signifying Maryland's stance on ensuring that medically necessary care aligning with a person's gender identity remains protected and that health care practitioners can perform their duties without facing undue discipline or scrutiny.

Companion Bills

MD SB119

Crossfiled Legally Protected Health Care - Gender-Affirming Treatment

Previously Filed As

MD SB859

Reproductive Health Protection Act

MD HB808

Reproductive Health Protection Act

MD HB283

Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act)

MD SB460

Maryland Medical Assistance Program – Gender–Affirming Treatment (Trans Health Equity Act)

MD SB582

Behavioral Health Care - Treatment and Access (Behavioral Health Model for Maryland)

MD HB1148

Behavioral Health Care - Treatment and Access (Behavioral Health Model for Maryland)

MD HB112

State Personnel - Whistleblower Law - Procedures and Remedies (First Amendment and Public Employee Protection Act)

MD SB786

Health - Reproductive Health Services - Protected Information and Insurance Requirements

MD HB722

Physician Assistants - Parity With Other Health Care Practitioners (Physician Assistant Parity Act of 2023)

MD SB674

Physician Assistants - Parity With Other Health Care Practitioners (Physician Assistant Parity Act of 2023)

Similar Bills

CA AB1944

Individualized investigational treatment.

SD HB1139

Allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.

IA SF233

A bill for an act relating to the right to try Act. (Formerly SF 56.) Effective date: 07/01/2025.

IA HF802

A bill for an act relating to the right to try Act.(Formerly HF 320.)

TX HB975

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.